BINA Daily: AI and Health — 2026-09-13

        September 13, 2026

BINA Daily: AI and Health — 2026-09-13

BINA DAILY · 2026-09-13

Today: AI policy and product news, plus the latest in health and medicine.

BINA DAILY · 2026-09-13

AI BRIEF

AI Safety Reaches Boiling Point: Executives Warn, Researchers Walk, Congress Mobilizes
Anthropic's CEO warns of AI agent swarms, OpenAI delays its IPO, leading researchers resign, and Congress moves to act — all in one week.
IN TODAY'S BRIEF

Dario Amodei Calls for a Slowdown — and Warns of Agent Swarms
Sam Altman Rules Out an OpenAI IPO in 2026 — Citing AI Safety
Top Researchers Leave Anthropic and Google DeepMind
US House Democrats Push to Cancel Congressional Recess for AI Safety
OpenAI Launches Agents API in Public Beta

Read the full AI brief →

HEALTH ROUNDUP

New Antifungal, H5N1 Vigilance, and Psilocybin's Six-Month Edge
A rare antifungal approval, updated H5N1 guidance, psilocybin trial data, prostate cancer survival gains, and a Cyprus heat advisory.
IN TODAY'S BRIEF

First-in-Class Antifungal Olorofim Approved for Refractory Aspergillosis
WHO Updates H5N1 Risk Assessment After New Cases in Southeast Asia
Psilocybin Shows Durable Six-Month Advantage Over Escitalopram in Depression Trial
Final Survival Data Strengthen PARP Inhibitor Case in Prostate Cancer
Real-World European Data Confirm RSV mRNA Vaccine Effectiveness, but Raise Questions for Over-80s
Cyprus and Eastern Mediterranean: September Heat Risk Continues for Elderly and Chronically Ill

Read the full health roundup →

BINA CYINNOVATION HUB · Larnaca · est. 2026

Unsubscribe

                                Don't miss what's next. Subscribe to Bina CyInnovation Daily Update:

                        Email
                        *

                    ← Newer

                BINA יומי: AI ובריאות — 2026-09-13

                    Older →

                BINA יומי: AI ובריאות — 2026-09-12